Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 04, 2023, titled "Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 04, 2023, titled "Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets".